Cargando…

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Foundation. Main funding source(s): The Innovation Fund Denmark BACKGROUND AND AIMS: Stroke is a leading cause of mortality and disability, and atrial fibrillation (AF) is an important and potentially modifiable risk factor for stroke. AF screening...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diederichsen, S Z, Xing, L Y, Haugan, K J, Hoejberg, S, Krieger, D, Brandes, A, Koeber, L, Frikke-Schmidt, R, Svendsen, J H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	10.3 - Diagnostic Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207047/ http://dx.doi.org/10.1093/europace/euad122.061

Ejemplares similares

Left atrial dimensions and left atrial appendage morphology: differences in paroxysmal versus persistent atrial fibrillation patients
por: Pongratz, J, et al.
Publicado: (2023)

Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection
por: Wouters, F, et al.
Publicado: (2023)

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation
por: Wijesurendra, R, et al.
Publicado: (2023)

Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation in primary prevention: a meta-analysis
por: Vetta, G, et al.
Publicado: (2023)

Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation
por: Hereijgers, M J M, et al.
Publicado: (2023)

Local conduction velocities determined by non-invasive electrocardiographic imaging predict arrhythmia-free survival after pulmonary vein isolation
por: Invers-Rubio, E, et al.
Publicado: (2023)

Combining atrial activation maps for the big picture of simulated atrial fibrillation mechanisms
por: Ozgul, O, et al.
Publicado: (2023)

Quantification of atrial cardiomyopathy disease severity by electroanatomic voltage mapping and cardiac magnetic resonance imaging
por: Sim, I, et al.
Publicado: (2023)

The relationship of plasma catestatin concentrations with the extension of left atrial fibrosis
por: Katic, J, et al.
Publicado: (2023)

The role of biomarkers, sleep apnea and echocardiography as predictors of atrial fibrillation in a pacemaker population
por: Santos Sanchez, A, et al.
Publicado: (2023)

New parameter of the second part of the P-wave predict atrial fibrillation: comparison with P-wave signal-averaged electrocardiography
por: Lee, Y, et al.
Publicado: (2023)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Correlation of NT-proBNP and left atrial pressure in patients with atypical atrial flutter after cardiac surgery and previous catheter ablation
por: Bakytzhanuly, A, et al.
Publicado: (2023)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
por: Jacobsen, Mads-Holger Bang, et al.
Publicado: (2023)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
por: António, Maria, et al.
Publicado: (2023)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
por: Welsh, Paul, et al.
Publicado: (2022)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
por: Legrand, Lise, et al.
Publicado: (2020)

Prognostic value of NT-proBNP in patients with severe COVID-19
por: Gao, Lei, et al.
Publicado: (2020)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
por: Reinhard, Henrik, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_47u351m60v20junafprabe8qv0